Advisory Board

 

Caring4Cancer
Medical Advisory Board

 

Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Chief, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute

James O. Armitage, MD
The Joe Shapiro Professor of Internal Medicine
Section of Oncology/Hematology
University of Nebraska Medical Center

Chandra P. Belani, MD
Deputy Director, Penn State Cancer Institute
Miriam Beckner Professor of Medicine
Penn State University School of Medicine

Howard A. Burris III, MD
Chief Medical Officer
Director of Drug Development
Sarah Cannon Research Institute
Tennessee Oncology

Jeremy R. Geffen, MD
President, Geffen Visions International
P4 Healthcare/Caring4Cancer

 

 

William J. Gradishar, MD
Professor of Medicine & Director of Breast Oncology
Robert H. Lurie Comprehensive Cancer Center
Feinberg School of Medicine
Northwestern University

Hagop M. Kantarjian, MD
Chairman, Department of Leukemia
Professor of Medicine & Internist
MD Anderson Cancer Center
University of Texas

Maurie Markman, MD
Vice President, Clinical Research
MD Anderson Cancer Center
University of Texas

Robert J. Motzer, MD
Attending Physician
Memorial Sloan-Kettering Cancer Center

Daniel P. Petrylak, MD
Associate Professor of Medicine
Director, Genitourinary Oncology Program
Columbia University Medical Center

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health